Drug major Novartis India Limited announced the appointment of Gira Sardesai as Additional Director in the category of Non-Executive Independent Director, with effect from March 31, 2024.
According to the company’s exchange filing, “Based on the recommendation of the Nomination and Remuneration Committee, the Board has approved the appointment of Ms. Gira Sardesai (DIN: 02610502) as an Additional Director (designated as Non-Executive and Independent Director) on the Board of the Company for a period of 5 (five) consecutive years with effect from March 31, 2024 up to March 30, 2029, subject to approval of the Members of the Company.”
Gira Sardesai, aged about 64 years, is a Chartered Accountant and Certified Public Accountant (CPA). Ms. Sardesai was earlier associated with companies like Pidilite Industries Limited, ICICI Bank, British Petroleum and Johnson & Johnson.
She is a dynamic and result oriented finance professional with more than 35 years of experience across different industries and multiple geographies. She holds extensive hands-on experience in management and business leadership, with an established record of success in significantly growing enterprise value.
Sardesai is proven ‘People’s leader’, holds the skills to effectively manage a large group of people and build highly competent teams to drive result delivery. She also exercises a high degree of discretion, mature judgment, and tact in handling issues of a sensitive nature. Sardesai also has extensively travelled across the world.
